GLP-3 RT (20mg)

GLP-3 RT (20mg)- Product will arrive in a lyophilized (powder) form for maximum stability.

GLP-3 RT is a triple agonist peptide that simultaneously activates three critical hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor (GCGR). By targeting all three pathways, GLP-3 RT offers a unique and comprehensive approach to regulating glucose metabolism, energy balance, and weight management.

This triple agonist approach goes beyond traditional single or dual incretin therapies. GLP-3 RT enhances insulin secretion and improves glycemic control through GLP-1 and GIP receptor stimulation, while the activation of the glucagon receptor promotes increased energy expenditure, fat utilization, and metabolic efficiency. Together, these mechanisms create a synergistic effect that addresses multiple aspects of type 2 diabetes, obesity, and metabolic syndrome.

Early research suggests that GLP-3 RT may provide superior outcomes compared to GLP-1 or dual agonists alone, including greater weight reduction, improved insulin sensitivity, enhanced lipid metabolism, and better long-term metabolic stability. Additionally, studies are investigating its potential in cardiovascular protection, liver health (NAFLD/NASH), and neuroendocrine regulation.